Pharmacotherapy in the Management of Anxiety and Pain During Acute Coronary Syndromes and the Risk of Developing Symptoms of Posttraumatic Stress Disorder

Original Research | By R von Känel, J-P Schmid, RE Meister-Langraf et al.

Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial

Original Research | By GG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.

Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia Burden

Original Research | By S Tankut, I Goldenberg, V Kutyifa et al.

When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease

Original Research | By E O'Meara, S Verma.

Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication

Original Research | By RD Kurmann, EA El-Am, YA Radwan et al.

Difference in basic concept of coronary bifurcation intervention between Korea and Japan. Insight from questionnaire in experts of Korean and Japanese bifurcation clubs

Review Article | By Y Murasato, Y Kinoshita, J Shite et al.

Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomized and multicenter DKCRUSH VIII trial

Clinical Trial | By Z Ge, JJ Zhang, SL Chen et al.

Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome

Original Research | By S Stojkovic, PP Wadowski, P Haider et al.

Late kidney injury after transcatheter aortic valve replacement

Original Research | By Y Adachi, M Yamamoto, OCEAN-TAVI investigators et al.

Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study

Original Research | By D Pellegrini, R Kawakami, G Guagliumi et al.